-Economic and Political Weekly Ten years on, the progressive provisions of the amended Indian Patents Act are being watered down. Ten years have passed since the Indian Patents Act, 1970 was amended in 2005 to bring the country’s laws in line with the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS). The most important of the 2005 amendments was the introduction of product patents for 20 years, including for pharmaceutical products,...
More »SEARCH RESULT
IMA asks doctors to prescribe cheapest version of drugs -Ramya Kannan
-The Hindu It was resolved that all IMA members shall write drugs with chemical or generic name in capital letters A resolution was passed at the recent working committee meeting of the Indian Medical Association (IMA) that is likely to have the direct benefit of making drugs more accessible and affordable. It was resolved that all IMA members “shall write drugs with chemical or generic name in capital letters, and the name of...
More »Driven to distress -R Krishnakumar
-Frontline Kerala is facing a situation where health care costs are leading more and more people, not just low-income families, to financial distress. KERALA is once again drawing attention to itself, this time for a persistent trend of a large number of households being pushed into financial ruin because of the expenses incurred for medical care. Several studies have now found evidence for the many facets of this worrying development in a...
More »Putting the ‘universal’ in healthcare -Lant Pritchett & Gulzar Natarajan
-The Indian Express Universal health coverage (UHC) is at the heart of the government's healthcare agenda. The 12th Five Year Plan targets a long-term goal of UHC where "each individual would have assured access to a defined essential range of medicines and treatment at an affordable price, which would be entirely free for a large percentage of the population". But this year's reduced budgetary allocation raises troublesome questions about its ability...
More »Duality finger at US drug patent call
-The Telegraph New Delhi: International health activists have joined their Indian counterparts in decrying what they say are Barack Obama's dual policy on big drug companies, pledging to break their stranglehold in the US but promoting their interests in India. The activists claimed yesterday that the India-US joint statement, issued during Obama's visit to India, contains signals that the Indian government could be preparing to weaken its intellectual property regulations on medicines,...
More »